OTC Markets OTCPK - Delayed Quote USD

Enzolytics, Inc. (ENZC)

Compare
0.0010
+0.0000
+(5.00%)
At close: January 10 at 3:00:00 PM EST
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for ENZC

Recent News: ENZC

View More
Bulgarian Academy of Sciences Issues Report on Results of Its In Vivo Testing of IPF as an Immunomodulator

Bulgarian Academy of Sciences Issues Report on Results of Its In Vivo Testing of IPF as an Immunomodulator
ACCESSWIRE 3 months ago
Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement

Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement
ACCESSWIRE 4 months ago
Final Report From the National Centre of Infectious and Parasitic Diseases Concludes Lyophilized Pepsin Significantly Reduces the Survival and Proliferation of Growth in Specific Cancer Cells

Final Report From the National Centre of Infectious and Parasitic Diseases Concludes Lyophilized Pepsin Significantly Reduces the Survival and Proliferation of Growth in Specific Cancer Cells
ACCESSWIRE 4 months ago
Enzolytics, Inc. and the Bulgarian Academy of Sciences Initiate a Cooperative Program Primarily Focusing on Applied and Strategic Research in Immunology for Cancer and HIV/AIDS Applications

Enzolytics, Inc. and the Bulgarian Academy of Sciences Initiate a Cooperative Program Primarily Focusing on Applied and Strategic Research in Immunology for Cancer and HIV/AIDS Applications
ACCESSWIRE 5 months ago
Enzolytics, Inc. Enters Into Collaboration Agreement With Manufacturer Elimus Ltd.

Enzolytics, Inc. Enters Into Collaboration Agreement With Manufacturer Elimus Ltd.
ACCESSWIRE 5 months ago
Enzolytics Inc. Supports Sagaliam Acquisition Corp Response to Competitors False and Misleading Press Release

Enzolytics Inc. Supports Sagaliam Acquisition Corp Response to Competitors False and Misleading Press Release
ACCESSWIRE 5 months ago

SAGALIUM RESPONDS TO COMPETITOR’S FALSE AND MISLEADING PRESS RELEASE
GlobeNewswire 5 months ago
Enzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer Treatment

Enzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer Treatment
ACCESSWIRE 6 months ago
Enzolytics, Inc. Poised to Invest Alongside Sagaliam Acquisition Corp in Revolutionary Room Temperature SPAD Technology

Enzolytics, Inc. Poised to Invest Alongside Sagaliam Acquisition Corp in Revolutionary Room Temperature SPAD Technology
ACCESSWIRE 7 months ago
Enzolytics, Inc. Announces Letter of Intent for Exclusive Licensing Agreement for Patented Nitric Oxide Formulation

Enzolytics, Inc. Announces Letter of Intent for Exclusive Licensing Agreement for Patented Nitric Oxide Formulation
ACCESSWIRE 7 months ago
Enzolytics, Inc. Announces Formation of Marketing Company in Partnership with Third Coast Fulfillment

Enzolytics, Inc. Announces Formation of Marketing Company in Partnership with Third Coast Fulfillment
ACCESSWIRE 8 months ago
View More

Related Tickers

HALB Halberd Corporation
0.0043
+16.22%
 
TSOI Therapeutic Solutions International, Inc.
0.0002
-33.33%
 
RGBP Regen BioPharma, Inc.
0.1000
+25.00%
 
PXMD PaxMedica, Inc.
0.0580
-10.77%
 
NWBO Northwest Biotherapeutics, Inc.
0.2700
+1.16%
 
ALDX Aldeyra Therapeutics, Inc.
4.9400
-3.33%
 
APLM Apollomics, Inc.
10.54
-1.68%
 
ATNFW 180 Life Sciences Corp.
0.0100
-4.76%
 
RSPI RespireRx Pharmaceuticals Inc.
0.0008
0.00%
 
VIRX Viracta Therapeutics, Inc.
0.1860
-0.91%